Fake Avastin Took Murky Path to U.S.

A second case of a counterfeit cancer drug reaching the U.S. market is focusing attention on the obscure overseas suppliers — sometimes operating in weakly regulated markets like Turkey — that are involved in shipping the medicines to U.S. doctors.
The Wall Street Journal